Loading
Jianzhijia Pharmaceutical Chain Group Co., Ltd. Stock: price and insider trades · China
健之佳
No insider purchase over the last 90 days. The latest, by 蓝心悦, was filed 25 Sept 2025.
Jianzhijia Pharmaceutical Chain Group Co., Ltd.: what insiders have been doing
Jianzhijia Pharmaceutical Chain Group Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Nothing new has been filed by managers of Jianzhijia Pharmaceutical Chain Group Co., Ltd. in twelve months, the latest record being from 25 September 2025.
Our records for Jianzhijia Pharmaceutical Chain Group Co., Ltd. go back to 2021, with 13 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
13
Thresholds
n/a
Buy Volume
€452,554
13 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySale蓝心悦3 buys
Since the insiders bought
- -20.4%Entry CN¥20.38 · Close 09 Oct 2026 CN¥16.23
- -50.0%Entry CN¥42.18 · Close at T+365 CN¥21.08
- -56.8%Entry CN¥49.68 · Close at T+365 CN¥21.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,754 of 26,320 companies
61.9
score / 100
Value83
Quality41
FCF yld42%
Earn yld6.0%
EV/EBITDA5.9x
ROE5.0%
Gross mgn36%
Net mgn1.7%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥16.04
Analyst consensus
Income statement
RevenueCN¥8.9B
Gross profitCN¥3.2B36% margin
EBITDACN¥1.1B13% margin
Net incomeCN¥148.1M1.5% margin
Valuation
PER (trailing)18.2x
P/Book0.9x
Beta0.52
Balance sheet & cash
Market capCN¥2.5B
Total debtCN¥4.3B
Free Cash FlowCN¥1B
Debt / Equity162%
Profitability & ownership
ROE5.0%
ROA2.3%
% insiders54.4%
% institutions3.5%
Last declaration on 25 September 2025
Declarations13 total
60,000 shares60.4% of flowA股XSHGSSE:173000009615165250
Canonical exit: 24 Dec 2025 (T+90)
8,600 shares8.7% of flowA股XSHGSSE:173000009393287870
Canonical exit: 9 Oct 2025 (T+90)
31,400 shares30.9% of flowA股XSHGSSE:173000009175246660
Canonical exit: 7 Oct 2025 (T+90)
1,000 shares25.1% of flowA股XSHGSSE:173000007621617540
Canonical exit: 6 Aug 2024 (T+90)
1,000 shares25.2% of flowA股XSHGSSE:173000007621617470
Canonical exit: 5 Aug 2024 (T+90)
6,600 shares100.0% of flowA股XSHGSSE:173000006909075620
Canonical exit: 6 Dec 2023 (T+90)
1,000 shares100.0% of flowA股XSHGSSE:173000006261598700
Canonical exit: 9 May 2023 (T+90)
6,060 shares48.6% of flowA股XSHGSSE:173000005918308640
Canonical exit: 29 Dec 2022 (T+90)
6,600 shares51.4% of flowA股XSHGSSE:173000005915855680
Canonical exit: 28 Dec 2022 (T+90)
1,000 shares24.8% of flowA股XSHGSSE:173000004585606240
Canonical exit: 21 Oct 2021 (T+90)
2,000 shares50.5% of flowA股XSHGSSE:173000004574035140
Canonical exit: 17 Oct 2021 (T+90)
1,000 shares24.7% of flowA股XSHGSSE:173000004455947870
Canonical exit: 1 Sept 2021 (T+90)
1,200 shares49.7% of flowA股XSHGSSE:173000004455947780
Canonical exit: 1 Sept 2021 (T+90)
13 of 13 declarations
About Jianzhijia Pharmaceutical Chain Group Co., Ltd.
健之佳 is a company operating in the health and pharmaceutical sector, listed on the XSHG market. It focuses on the development and distribution of pharmaceutical and healthcare products.
